HPV 16+ Recurrent or Metastatic Cancer

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Papivax
PapivaxTaiwan - Taipei
1 program
1
CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16Phase 1/21 trial
Active Trials
NCT04713046RecruitingEst. Oct 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
PapivaxCD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16

Clinical Trials (1)

NCT04713046PapivaxCD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

Start: Oct 2023Est. completion: Oct 2026
Phase 1/2Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
16m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
16m ago

Office Administrator

SystImmune
16m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
27m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
30m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
30m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)